StudyFinder



Clear

Search Results

Here are the studies that match your search criteria. If you are interested in participating, please reach out to the contact listed for the study. If no contact is listed, contact us and we'll help you find the right person.

1 Study Matches

A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF DAPIROLIZUMAB PEGOL IN STUDY PARTICIPANTS WITH MODERATELY TO SEVERELY ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS

A randomized placebo-controlled study to evaluate the efficacy and safety of dapirolizumab pegol in study participants with moderately to severely active systemic lupus erythematosus

There is up to 15 visits over the course of 54 weeks. Lab samples will be collected, medication will be administered.

amount varies based on visits completed

Nancy Olsen
Jamie Carter - at jcarter3@pennstatehealth.psu.edu or 717-531-0003, ext=283833
 

All
All
This study is NOT accepting healthy volunteers
NCT04294667
STUDY00017186
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
≥16 years of age
≥40kg and ≤160kg
diagnosis of Systemic lupus erythematosus (SLE)
Exclusion Criteria:
pregnancy
history of chronic alcohol or drug abuse
known history of allergic reaction to the drug
Arthritis & Rheumatic Diseases
Experimental drug compared to a placebo/”sugar pill”
I'm interested
Share via email
See this study on ClinicalTrials.gov
Show 1 location

Study Locations

Hide all locations
Location Contacts
Hershey, PA ,